Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC and CBD for Co-Occurring OUD and Chronic Pain
NCT06544291Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Oct 2024
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, cannabidiol in opioid use disorder (OUD), chronic pain, sponsored by Yale University. Started Oct 2024; status: recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
opioid use disorder (OUD)chronic pain
Beyond the preview
Go deeper on NCT06544291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06544291.